Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 5 studies | 33% ± 19% | |
| myofibroblast cell | 5 studies | 24% ± 10% | |
| pericyte | 4 studies | 22% ± 7% | |
| smooth muscle cell | 3 studies | 29% ± 6% |
Insufficient scRNA-seq data for expression of FOXF2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 99% | 5064.79 | 1425 / 1445 | 99% | 19.13 | 181 / 183 |
| lung | 100% | 1770.70 | 577 / 578 | 93% | 13.31 | 1074 / 1155 |
| stomach | 99% | 1440.50 | 356 / 359 | 93% | 14.51 | 266 / 286 |
| intestine | 98% | 3126.70 | 949 / 966 | 88% | 9.03 | 462 / 527 |
| bladder | 90% | 1092.10 | 19 / 21 | 85% | 11.15 | 428 / 504 |
| brain | 72% | 286.29 | 1911 / 2642 | 96% | 9.81 | 675 / 705 |
| prostate | 81% | 1095.47 | 198 / 245 | 77% | 7.05 | 388 / 502 |
| breast | 54% | 188.73 | 248 / 459 | 73% | 4.09 | 820 / 1118 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.58 | 1 / 1 |
| thymus | 74% | 353.59 | 481 / 653 | 23% | 1.55 | 142 / 605 |
| pancreas | 2% | 7.06 | 8 / 328 | 94% | 9.77 | 167 / 178 |
| eye | 0% | 0 | 0 / 0 | 91% | 9.18 | 73 / 80 |
| skin | 28% | 131.31 | 511 / 1809 | 63% | 10.59 | 297 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 6.57 | 38 / 45 |
| uterus | 1% | 1.62 | 1 / 170 | 62% | 7.73 | 285 / 459 |
| ovary | 1% | 4.59 | 2 / 180 | 38% | 1.89 | 164 / 430 |
| adipose | 25% | 72.11 | 295 / 1204 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 11% | 0.94 | 46 / 406 |
| kidney | 0% | 0 | 0 / 89 | 8% | 0.60 | 75 / 901 |
| adrenal gland | 1% | 4.24 | 2 / 258 | 7% | 0.24 | 15 / 230 |
| blood vessel | 3% | 9.24 | 41 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 1% | 2.17 | 6 / 803 | 0% | 0 | 0 / 0 |
| heart | 1% | 1.92 | 6 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0032434 | Biological process | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO_0001837 | Biological process | epithelial to mesenchymal transition |
| GO_0048596 | Biological process | embryonic camera-type eye morphogenesis |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0048566 | Biological process | embryonic digestive tract development |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0048806 | Biological process | genitalia development |
| GO_0060021 | Biological process | roof of mouth development |
| GO_1902914 | Biological process | regulation of protein polyubiquitination |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0042249 | Biological process | establishment of planar polarity of embryonic epithelium |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016604 | Cellular component | nuclear body |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0001093 | Molecular function | TFIIB-class transcription factor binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0140296 | Molecular function | general transcription initiation factor binding |
| Gene name | FOXF2 |
| Protein name | Forkhead box protein F2 (Forkhead-related activator 2) (FREAC-2) (Forkhead-related protein FKHL6) (Forkhead-related transcription factor 2) |
| Synonyms | FREAC2 FKHL6 |
| Description | FUNCTION: Probable transcription activator for a number of lung-specific genes . Mediates up-regulation of the E3 ligase IRF2BPL and drives ubiquitination and degradation of CTNNB1 . . |
| Accessions | Q12947 ENST00000645481.2 |